Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response
THOC5 could be a prognostic biomarker and therapeutic target in LIHC and various cancers, providing alternative treatment options when immunotherapy fails.
Authors
- Jinshu Pang (ORCID: https://orcid.org/0000-0002-1919-4859)
- Jin-Dan Li
- Yun He (ORCID: https://orcid.org/0000-0002-2818-1953)
- Hong Yang (ORCID: https://orcid.org/0009-0002-0414-2471)
- Xiu-Mei Bai (ORCID: https://orcid.org/0000-0001-9581-6851)
- Lipeng Li
- Yang Yu (ORCID: https://orcid.org/0000-0002-5481-5382)
- Liang Li (ORCID: https://orcid.org/0000-0002-3079-1443)
- Xiang Wei (ORCID: https://orcid.org/0000-0003-0838-8583)
- Rong Wen (ORCID: https://orcid.org/0000-0003-4864-2929)
- Ruizhi Gao (ORCID: https://orcid.org/0000-0001-9847-3081)
- Yujia Zhao
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3389/fmed.2025.1596120
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00